Biomedical Engineering Reference
In-Depth Information
50. Liu AN, et al. Perforin-independent CD8(
þ
) T-cell-mediated cytotoxicity of
alveolar epithelial cells is preferentially mediated by tumor necrosis factor-
alpha: relative insensitivity to Fas ligand. Am J Respir Cell Mol Biol 1999;
20:849-858.
51. Hashimoto S, et al. Upregulation of two death pathways of perforin
=
granzyme
and FasL
=
Fas in septic acute respiratory distress syndrome. Am J Respir Crit
Care Med 2000; 161:237-243.
52. Donaldson GC, et al. Relationship between exacerbation frequency and lung
function decline in chronic obstructive pulmonary disease. Thorax 2002;
57:847-852.
53. Enelow RI, et al. Structural and functional consequences of alveolar cell recog-
nition by CD8
þ
T lymphocytes in experimental lung disease. J Clin Invest
1998; 102:1653-1661.
54. Majo J, Ghezzo H, Cosio MG. Lymphocyte population and apoptosis in the
lungs of smokers and their relation to emphysema. Eur Respir J 2001;
17:946-953.
55. Kasahara Y, et al. Inhibition of VEGF receptors causes lung cell apoptosis and
emphysema. J Clin Invest 2000; 106:1311-1319.
56. Romagnani S. The Thl
=
Th2 paradigm. Immunol Today 1997; 18:263-266.
57. Saetta M, et al. Increased expression of the chemokine receptor CXCR3 and its
ligand CXCLI0 in peripheral airways of smokers with chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2002; 165:1404-1409.
58. Sallusto F, et al. Flexible programs of chemokine receptor expression on
human polarized Thelper 1 and 2 lymphocytes. J Exp Med 1998; 187:875-883.
59. Saetta M, et al. Loss of alveolar attachments in smokers. A morphometric
correlate of lung function impairment. Am Rev Respir Dis 1985; 132:894-900.
60. Turato G, et al. Airway inflammation in severe chronic obstructive pulmonary
disease: relationship with lung function and radiologic emphysema. Am J
Respir Crit Care Med 2002; 166:105-110.
61. Shapiro SD. End-stage chronic obstructive pulmonary disease: the cigarette is
burned out but inflammation rages on. Am J Respir Crit Care Med 2001;
164:339-340.
62. Kim WD, et al. Centrilobular and panlobular emphysema in stnokers. Two
distinct morphologic and functional entities. Am Rev Respir Dis 1991; 144:
1385-1390.
63. Saetta M, et al. Extent of centrilobular and panacinar emphysema in smokers'
lungs: pathological and mechanical implications. Eur Respir J 1994; 7:664-671.
64. Cosio MG, Cosio Piqueras MG. Pathology of emphysema in chronic obstruc-
tive pulmonary disease. Monaldi Arch Chest Dis 2000; 55:124-129.
65. Vlahovic G. et al. Cellular and connective tissue changes in alveolar septal walls
in emphysema. Am J Respir Crit Care Med 1999; 160:2086-2092.
66. Lang MR, et al. Collagen content of alveolar wall tissue in emphysematous and
non-emphysematous lungs. Thorax 1994; 49:319-326.
67. Standards for the diagnosis and care of patients with chronic obstructive
pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med
1995; 152:S77-S121.
